CRISPR Therapeutics AG’s Shares Reel: -0.48% Quarterly Revenue Decline Amid 4.21B Market Cap
The market performance of CRISPR Therapeutics AG’s stock has been harmonious in recent times. Over the last year, the company’s stock reached its highest point at $91.10 on 02/22/24, while the lowest value for the same duration was $39.76 on 09/06/24. 52-week price history of